{"id":20240,"date":"2023-04-10T11:32:39","date_gmt":"2023-04-10T03:32:39","guid":{"rendered":"https:\/\/tbenews.com\/tbe\/?p=20240"},"modified":"2023-04-10T11:32:40","modified_gmt":"2023-04-10T03:32:40","slug":"snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease","status":"publish","type":"post","link":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/","title":{"rendered":"Snapshot week 15\/2023
TBE vaccine field effectiveness against severe and mild forms of disease"},"content":{"rendered":"\n

Santonja et al.
Tick-borne encephalitis in vaccinated patients: A retrospective case-control study and analysis of vaccination field effectiveness in Austria from 2000 to 2018
J Infect Dis.<\/em> 2023;227(4):512-521. doi:10.1093\/infdis\/jiac075<\/p>\n\n\n\n

The field effectiveness of TBE vaccination is high and has been estimated to range over 95% in various countries. Nevertheless, TBE can occur rarely in individuals with a history of vaccination and is more likely to happen in populations with a high vaccination rate, like Austria, where over 80% of the population has received at least one injection of TBE vaccine and more than 60% has received full vaccination according to the recommended schedule.<\/p>\n\n\n\n

In a case-control study, it was aimed to determine the proportion of mild and severe forms of TBE in vaccinated and matched non-vaccinated patients. In addition, the field effectiveness against mild and severe forms of TBE virus infections has been calculated. The retrospective longitudinal study was performed in Austria based on 1545 patients between 2000 and 2018 of whom 206 patients (13.3%) had been vaccinated and 1245 had never been vaccinated. For the remaining 94 patients, no vaccination status was available.<\/p>\n\n\n\n

A higher proportion of severe cases was observed in vaccinated individuals compared to non-vaccinated persons. This observation is the consequence of a slightly lower field effectiveness against severe forms of TBE (94.7%\u201395.8%) compared to milder forms (97.1%\u201397.8%). This difference was especially pronounced in children 1\u201316 years of age with 82.7% for severe forms and 94.7%\u201395.6% for mild forms of TBE.<\/p>\n\n\n\n

The results confirm the excellent field effectiveness of TBE vaccination and also the somewhat lower protection rate in children, which may be related to the pediatric-dose vaccine (half the amount of antigen compared to the vaccine for adults).<\/p>\n<\/span>","protected":false},"excerpt":{"rendered":"

Santonja et al.Tick-borne encephalitis in vaccinated patients: A retrospective case-control study and analysis of vaccination field effectiveness in Austria from 2000 to 2018J Infect Dis. 2023;227(4):512-521. doi:10.1093\/infdis\/jiac075 The field effectiveness of TBE vaccination is high and has been estimated to range over 95% in various countries. Nevertheless, TBE can occur rarely in individuals with a history of vaccination and is more likely to happen in populations with a high vaccination rate, like Austria, where over 80% of the population has received at least one injection of TBE vaccine and more than 60% has received full vaccination according to the recommended schedule. In a case-control study, it was aimed to determine the proportion of mild and severe forms of TBE in vaccinated and matched non-vaccinated patients. In addition, the field effectiveness against mild and severe forms of TBE virus infections has been calculated. The retrospective longitudinal study was performed in Austria based on 1545 patients between 2000 and 2018 of whom 206 patients (13.3%) had been vaccinated and 1245 had never been vaccinated. For the remaining 94 patients, no vaccination status was available. A higher proportion of severe cases was observed in vaccinated individuals compared to non-vaccinated persons. This observation is the consequence of a slightly lower field effectiveness against severe forms of TBE (94.7%\u201395.8%) compared to milder forms (97.1%\u201397.8%). This difference was especially pronounced in children 1\u201316 years of age with 82.7% for severe forms and 94.7%\u201395.6% for mild forms of TBE. The results confirm the excellent field effectiveness of TBE vaccination and also the somewhat lower protection rate in children, which may be related to the pediatric-dose vaccine (half the amount of antigen compared to the vaccine for adults).<\/p>\n","protected":false},"author":1354,"featured_media":12864,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[18],"tags":[292,360,991,992,990],"coauthors":[581],"class_list":["post-20240","post","type-post","status-publish","format-standard","has-post-thumbnail","category-snapshot","tag-austria","tag-children","tag-disease-severity","tag-vaccination-failure","tag-vaccine-filed-effectiveness"],"yoast_head":"\nSnapshot week 15\/2023 TBE vaccine field effectiveness against severe and mild forms of disease - TBE Book<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Snapshot week 15\/2023 TBE vaccine field effectiveness against severe and mild forms of disease - TBE Book\" \/>\n<meta property=\"og:description\" content=\"Santonja et al.Tick-borne encephalitis in vaccinated patients: A retrospective case-control study and analysis of vaccination field effectiveness in Austria from 2000 to 2018J Infect Dis. 2023;227(4):512-521. doi:10.1093\/infdis\/jiac075 The field effectiveness of TBE vaccination is high and has been estimated to range over 95% in various countries. Nevertheless, TBE can occur rarely in individuals with a history of vaccination and is more likely to happen in populations with a high vaccination rate, like Austria, where over 80% of the population has received at least one injection of TBE vaccine and more than 60% has received full vaccination according to the recommended schedule. In a case-control study, it was aimed to determine the proportion of mild and severe forms of TBE in vaccinated and matched non-vaccinated patients. In addition, the field effectiveness against mild and severe forms of TBE virus infections has been calculated. The retrospective longitudinal study was performed in Austria based on 1545 patients between 2000 and 2018 of whom 206 patients (13.3%) had been vaccinated and 1245 had never been vaccinated. For the remaining 94 patients, no vaccination status was available. A higher proportion of severe cases was observed in vaccinated individuals compared to non-vaccinated persons. This observation is the consequence of a slightly lower field effectiveness against severe forms of TBE (94.7%\u201395.8%) compared to milder forms (97.1%\u201397.8%). This difference was especially pronounced in children 1\u201316 years of age with 82.7% for severe forms and 94.7%\u201395.6% for mild forms of TBE. The results confirm the excellent field effectiveness of TBE vaccination and also the somewhat lower protection rate in children, which may be related to the pediatric-dose vaccine (half the amount of antigen compared to the vaccine for adults).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"TBE Book\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-10T03:32:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-10T03:32:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Shaqeez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaqeez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/\"},\"author\":{\"name\":\"Shaqeez\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/person\\\/2bc2ab1f56f93257537a0ce8de903224\"},\"headline\":\"Snapshot week 15\\\/2023 TBE vaccine field effectiveness against severe and mild forms of disease\",\"datePublished\":\"2023-04-10T03:32:39+00:00\",\"dateModified\":\"2023-04-10T03:32:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/\"},\"wordCount\":280,\"publisher\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"keywords\":[\"Austria\",\"children\",\"disease severity\",\"Vaccination failure\",\"vaccine filed effectiveness\"],\"articleSection\":[\"Snapshot\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/\",\"name\":\"Snapshot week 15\\\/2023 TBE vaccine field effectiveness against severe and mild forms of disease - TBE Book\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"datePublished\":\"2023-04-10T03:32:39+00:00\",\"dateModified\":\"2023-04-10T03:32:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"contentUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"width\":1180,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Snapshot week 15\\\/2023 TBE vaccine field effectiveness against severe and mild forms of disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#website\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\",\"name\":\"The TBE Book\",\"description\":\"Tick-borne Encephalitis (TBE)\",\"publisher\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\",\"name\":\"Global Health Press\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/logo-PNG.png\",\"contentUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/logo-PNG.png\",\"width\":1000,\"height\":715,\"caption\":\"Global Health Press\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/person\\\/2bc2ab1f56f93257537a0ce8de903224\",\"name\":\"Shaqeez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g2ce4daa834e38f5ff18a9faa82d1596d\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g\",\"caption\":\"Shaqeez\"},\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/author\\\/shaqeez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Snapshot week 15\/2023 TBE vaccine field effectiveness against severe and mild forms of disease - TBE Book","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/","og_locale":"en_US","og_type":"article","og_title":"Snapshot week 15\/2023 TBE vaccine field effectiveness against severe and mild forms of disease - TBE Book","og_description":"Santonja et al.Tick-borne encephalitis in vaccinated patients: A retrospective case-control study and analysis of vaccination field effectiveness in Austria from 2000 to 2018J Infect Dis. 2023;227(4):512-521. doi:10.1093\/infdis\/jiac075 The field effectiveness of TBE vaccination is high and has been estimated to range over 95% in various countries. Nevertheless, TBE can occur rarely in individuals with a history of vaccination and is more likely to happen in populations with a high vaccination rate, like Austria, where over 80% of the population has received at least one injection of TBE vaccine and more than 60% has received full vaccination according to the recommended schedule. In a case-control study, it was aimed to determine the proportion of mild and severe forms of TBE in vaccinated and matched non-vaccinated patients. In addition, the field effectiveness against mild and severe forms of TBE virus infections has been calculated. The retrospective longitudinal study was performed in Austria based on 1545 patients between 2000 and 2018 of whom 206 patients (13.3%) had been vaccinated and 1245 had never been vaccinated. For the remaining 94 patients, no vaccination status was available. A higher proportion of severe cases was observed in vaccinated individuals compared to non-vaccinated persons. This observation is the consequence of a slightly lower field effectiveness against severe forms of TBE (94.7%\u201395.8%) compared to milder forms (97.1%\u201397.8%). This difference was especially pronounced in children 1\u201316 years of age with 82.7% for severe forms and 94.7%\u201395.6% for mild forms of TBE. The results confirm the excellent field effectiveness of TBE vaccination and also the somewhat lower protection rate in children, which may be related to the pediatric-dose vaccine (half the amount of antigen compared to the vaccine for adults).","og_url":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/","og_site_name":"TBE Book","article_published_time":"2023-04-10T03:32:39+00:00","article_modified_time":"2023-04-10T03:32:40+00:00","og_image":[{"width":1180,"height":250,"url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","type":"image\/jpeg"}],"author":"Shaqeez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Shaqeez","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/#article","isPartOf":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/"},"author":{"name":"Shaqeez","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/person\/2bc2ab1f56f93257537a0ce8de903224"},"headline":"Snapshot week 15\/2023 TBE vaccine field effectiveness against severe and mild forms of disease","datePublished":"2023-04-10T03:32:39+00:00","dateModified":"2023-04-10T03:32:40+00:00","mainEntityOfPage":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/"},"wordCount":280,"publisher":{"@id":"https:\/\/tbenews.com\/tbe\/#organization"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","keywords":["Austria","children","disease severity","Vaccination failure","vaccine filed effectiveness"],"articleSection":["Snapshot"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/","url":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/","name":"Snapshot week 15\/2023 TBE vaccine field effectiveness against severe and mild forms of disease - TBE Book","isPartOf":{"@id":"https:\/\/tbenews.com\/tbe\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/#primaryimage"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","datePublished":"2023-04-10T03:32:39+00:00","dateModified":"2023-04-10T03:32:40+00:00","breadcrumb":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/#primaryimage","url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","contentUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","width":1180,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-15-2023-tbe-vaccine-field-effectiveness-against-severe-and-mild-forms-of-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tbenews.com\/tbe\/"},{"@type":"ListItem","position":2,"name":"Snapshot week 15\/2023 TBE vaccine field effectiveness against severe and mild forms of disease"}]},{"@type":"WebSite","@id":"https:\/\/tbenews.com\/tbe\/#website","url":"https:\/\/tbenews.com\/tbe\/","name":"The TBE Book","description":"Tick-borne Encephalitis (TBE)","publisher":{"@id":"https:\/\/tbenews.com\/tbe\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tbenews.com\/tbe\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/tbenews.com\/tbe\/#organization","name":"Global Health Press","url":"https:\/\/tbenews.com\/tbe\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/logo\/image\/","url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2019\/01\/logo-PNG.png","contentUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2019\/01\/logo-PNG.png","width":1000,"height":715,"caption":"Global Health Press"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/person\/2bc2ab1f56f93257537a0ce8de903224","name":"Shaqeez","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g2ce4daa834e38f5ff18a9faa82d1596d","url":"https:\/\/secure.gravatar.com\/avatar\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g","caption":"Shaqeez"},"url":"https:\/\/tbenews.com\/tbe\/author\/shaqeez\/"}]}},"_links":{"self":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/20240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/users\/1354"}],"replies":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/comments?post=20240"}],"version-history":[{"count":1,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/20240\/revisions"}],"predecessor-version":[{"id":20241,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/20240\/revisions\/20241"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/media\/12864"}],"wp:attachment":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/media?parent=20240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/categories?post=20240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/tags?post=20240"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/coauthors?post=20240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}